David P. Calfee
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 27
-
- Antibiotic Resistance in Bacteria 25
- Co-authors
- Barry M. FarrCassandra D. SalgadoStephen G. JenkinsGopi PatelStephanie H. FactorShirish HuprikarE. Yoko FuruyaChristine J. Kubin
- Journals
- Infection Control and Hospital Epidemiology (37 papers)Open Forum Infectious Diseases (15 papers)American Journal of Infection Control (6 papers)Annals of Internal Medicine (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- United StatesAustraliaSingapore
In The Last Decade
David P. Calfee
103 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Applied Microbiology and Biotechnology 866
- Molecular Medicine 1.6k
- Clinical Biochemistry 1.1k
- Infectious Diseases 1.8k
- Endocrinology 428
Countries citing papers authored by David P. Calfee
This map shows the geographic impact of David P. Calfee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Calfee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Calfee more than expected).
Fields of papers citing papers by David P. Calfee
This network shows the impact of papers produced by David P. Calfee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Calfee. The network helps show where David P. Calfee may publish in the future.
Co-authors
The 25 scholars most cited alongside David P. Calfee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 52 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 55 | |
| 12 | 2019 | 13 | |
| 13 | 2019 | 116 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 28 | |
| 16 | 2011 | 22 | |
| 17 | 2008 | 117 | |
| 18 | Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Hit paper breakdown → | 2008 | 679 |
| 19 | 2003 | 21 | |
| 20 | 1999 | 10 |
About David P. Calfee
David P. Calfee is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Microbiology, having authored 111 papers that have together received 4.5k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (34 papers), Antimicrobial Resistance in Staphylococcus (31 papers), Antibiotic Use and Resistance (27 papers), Antibiotic Resistance in Bacteria (25 papers), Infection Control in Healthcare (23 papers), Clostridium difficile and Clostridium perfringens research (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Streptococcal Infections and Treatments (10 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (866 citations), Molecular Medicine (1.6k citations), Clinical Biochemistry (1.1k citations), Infectious Diseases (1.8k citations) and Endocrinology (428 citations). David P. Calfee has collaborated with scholars based in United States, Australia and Singapore. Frequent co-authors include Barry M. Farr, Cassandra D. Salgado, Stephen G. Jenkins, Gopi Patel, Stephanie H. Factor, Shirish Huprikar, E. Yoko Furuya, Christine J. Kubin, Amy Peng and Frederick G. Hayden. Their work appears in journals such as Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, American Journal of Infection Control, Annals of Internal Medicine and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.